martes, 16 de junio de 2026
Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Ocular Myasthenia Gravis by Madaline Spencer| Published on: Jun 16, 2026
Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Ocular Myasthenia Gravis
by Madaline Spencer| Published on: Jun 16, 2026
Carolina Barnett-Tapia, MD, Neuromuscular Neurologist and the University of Toronto, discusses the safety and efficacy of subcutaneous efgartigimod PH20 in ocular myasthenia gravis (oMG).
https://checkrare.com/safety-and-efficacy-of-subcutaneous-efgartigimod-ph20-in-ocular-myasthenia-gravis/
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario